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PCR amplification of insertion element IS6110 of Mycobacterium tuberculosis in fecal samples was evaluated
in the diagnosis of intestinal tuberculosis (ITB). The numbers of samples that tested positive by PCR with SalI
digestion were 16/18 untreated-ITB samples, 0/8 treated-ITB samples, 12/14 smear-positive pulmonary tuber-
culosis samples, and 0/30 control samples. The sensitivity, specificity, positive predictive value, and negative
predictive value of fecal PCR were 88.8%, 100%, 100%, and 93.7%, respectively.
Tuberculosis (TB) infection affects a third of the world’s
population (4). Gastrointestinal TB mimics many conditions,
including inflammatory bowel disease, malignancy, and infec-
tious diarrhea, and is often difficult to diagnose (7, 17). With
colonic disease, endoscopy and biopsy may confirm the diag-
nosis (13, 16), while surgical biopsy is necessary with disease
confined to the small intestine. By use of mucosal biopsies,
Mycobacterium tuberculosis is demonstrated by culture to occur
in one-third (2) and by PCR in two-thirds (6) of patients with
colonic TB. In countries with a high incidence of TB, gastro-
intestinal tuberculosis is often diagnosed and treated on em-
pirical grounds and confirmed by resolution following therapy.
This study evaluated the ability of PCR of feces to amplify the
IS6110 insertion element of M. tuberculosis in the diagnosis of
gastrointestinal TB.
Consecutive patients with intestinal tuberculosis seen in the
Department of Gastrointestinal Sciences between April 2003
and January 2005 were included. The diagnosis was made on
the basis of one of the following criteria: (i) intestinal biopsies
showing caseating granulomas, (ii) intestinal granulomas ac-
companied by confirmed extraintestinal tuberculosis, (iii) en-
doscopic findings of TB with noncaseating granulomas on bi-
opsy and complete resolution after antituberculosis therapy, or
(iv) culture of M. tuberculosis from intestinal biopsy specimens.
All patients were negative for acid-fast bacilli in induced-spu-
tum specimens. Twenty-four subjects with irritable bowel syn-
drome (all with normal hematology and colonoscopy) under-
going colonoscopy during this period and six healthy adult
volunteers served as controls. Fourteen patients with pulmo-
nary TB and acid-fast bacilli on Ziehl-Neelsen stain of sputum
smears were recruited from the DOTS Clinic of Christian
Medical College, Vellore, India. Eight patients with intestinal
tuberculosis who completed 9 months of antituberculosis ther-
apy and were clinically symptom free with normal hemoglobin,
sedimentation rate, serum albumin, and globulin were in-
cluded. The protocol and consent forms were approved by the
Research Committee of the Christian Medical College, Vel-
lore, India.
Fresh feces were collected after consent and stored at
20°C. Feces (250 mg) were homogenized in 2 ml sterile
phosphate-buffered saline and heated at 90°C for 15 min. After
centrifugation (500  g, 3 min), the supernatant was mixed
with lysozyme (10 mg/ml) (Genei, India) and incubated at 37°C
for 1 h; then, proteinase K (Genei, India) (30 mg/ml) and 20%
sodium dodecyl sulfate (Sigma, India) were added, and the
mixture was incubated at 55°C for 2 h. Following centrifuga-
tion (9,000  g, 10 min) nucleic acid was extracted from the
supernatant by using equal volumes of equilibrated phenol
(pH 8.0; Ambion) and chloroform-isoamyl alcohol (25:24:1).
DNA was precipitated with ethanol and 2.5 M ammonium
acetate (2.0:0.1, 20°C, 1 h), pelleted (18,000  g, 20 min),
washed with 70% ethanol, air dried, resuspended in 50 l
sterile water, and stored at 20°C (12). A positive control was
prepared from killed culture of Mycobacterium tuberculosis
strain H37Rv. The primers used (MTB1, 5 CCT GCG AGC
GTA GGC GTC GG 3, and MTB2, 5 CTC GTC CAG CGC
CGC TTC GG 3) amplified a 123-bp fragment of IS6110 (5),
which is specific for M. tuberculosis and contains an internal
endonuclease site that allows confirmation of the product by
digestion with SalI. PCR amplification in 10 l used titanium
Taq polymerase (BD Biosciences Clontech) and 10 pmol of
each primer (Sigma, Bangalore, India). The final PCR condi-
tions consisted of an initial denaturation at 95°C for 30 s,
followed by 40 cycles of denaturation (94°C, 30 s), annealing
(68°C, 30 s), and extension (72°C, 30 s), with a final extension
for 10 min. The PCR product was subjected to electrophoresis
on 2% agarose, stained with ethidium bromide, and imaged
(Bio-Rad). The PCR products were digested with 10 U/l of
SalI (MBI Fermentas) at 37°C overnight, followed by electro-
phoresis on 3% agarose. Specificity of the primers was tested
by sequence searches against prokaryotic DNA databases, in
silico PCRs, and PCR using DNA from atypical mycobacte-
ria—M. avium, M. kansasii, and M. fortuitum. Serial 10-fold
dilutions of M. tuberculosis H37Rv (3) were added to PCR-
negative fecal samples to establish the detection limit of PCR.
* Corresponding author. Mailing address: Department of Gastrointes-
tinal Sciences, Christian Medical College, Ida Scudder Road, Vellore
632004, Tamil Nadu, India. Phone: 91 416 2282052. Fax: 91 416 2232035.
E-mail: rama@cmcvellore.ac.in.
1884
All samples that tested positive were reconfirmed using two
additional DNA extracts.
PCR using M. tuberculosis H37Rv, but not atypical myco-
bacteria, produced a 123-bp amplicon (Fig. 1, top left). With
serial dilutions, PCR was able to detect 10 copies of M.
tuberculosis. SalI digestion of the PCR product from positive
cases and the positive control produced two bands, one of 66
bp and one of 57 bp, respectively (Fig. 1, bottom left). The
specific PCR product was noted for 16 of 18 patients with
untreated intestinal tuberculosis (Fig. 1, top right). Samples
were negative by PCR for all 30 control subjects (Fig. 1, top
left) and all eight treated gastrointestinal TB patients, five of
whom were tested prior to therapy and were positive and
three of whom were not tested prior to therapy. Twelve of 14
patients with smear-positive pulmonary tuberculosis tested
positive (Fig. 1, bottom right), indicating fecal excretion of
swallowed organisms. The sensitivity of fecal PCR for the di-
agnosis of intestinal TB was 88.8%, and the specificity was
100% (Table 1). In comparison to results with fecal PCR, 9/18
and 6/18 patients with intestinal TB tested positive by histopa-
thology and culture, indicating sensitivities of 50% and 33.3%,
respectively.
PCR is used increasingly in the diagnosis of tuberculosis (1).
For smear-positive pulmonary TB, PCR confirms or excludes
the diagnosis in 48 h, compared to culture, which takes 2 to 8
weeks (8). PCR of mucosal biopsy specimens diagnoses colonic
TB in 45 to 64% of cases (6, 9). Unlike endoscopic biopsy, fecal
PCR is noninvasive, and it is also less subject to sampling error.
Stool PCR for atypical mycobacteria has been used for patients
with human immunodeficiency virus (10). The IS6110 se-
quence is present in most clinical isolates of M. tuberculosis;
however, 4/378 (1%) isolates and 19/80 (24%) isolates in two
studies from southern India showed an absence of even a single
copy of IS6110 (11, 14). As with intestinal TB samples, un-
treated-pulmonary-TB samples were positive by fecal PCR,
likely due to swallowed M. tuberculosis. Gastric lavage is used
widely to diagnose infection in adults and children with pul-
monary TB who do not expectorate sputum (15, 18). This study
suggests that fecal PCR will achieve the same end. Fecal PCR
for the IS6110 sequence is thus an attractive test for the
diagnosis and follow-up of intestinal TB. Its utility in distin-
guishing patients with Crohn’s disease from those with TB and
in identifying patients with active pulmonary TB needs further
study.
FIG. 1. Electrophoresis of PCR products on a 2% agarose gel (top panels and bottom right panel) or PCR product digest on a 3% agarose gel
(bottom left panel). In each panel, lane M is the molecular weight marker. (Top left) Lanes 1 to 11 are DNA isolated from feces of control subjects.
Lane 12 shows amplification of a 123-bp fragment from the positive-control DNA. (Bottom left) Digested PCR products, showing 66- and 57-bp
fragments. Lanes 1 to 6, results from intestinal TB patients; lanes 7 and 8, results from pulmonary TB patients. Lane 9 is the positive control. (Top
right) Lanes 1 to 11 show results from various intestinal TB patients, while lane 12 is a positive control. (Bottom right) Lanes 1 to 11 show results
from patients with smear-positive pulmonary TB, while lane 12 shows the positive control.
TABLE 1. Outcome of fecal PCR for IS6110 of M. tuberculosis in
the various groups studied
Parameter
Value for group
Intestinal
TB Control
Sputum-positive
pulmonary TB
Treated
intestinal TB
Fecal PCR positive
(no. of samples)
16 0 12 0
Fecal PCR negative
(no. of samples)
2 30 2 8
Sensitivity (%) 88.8 88.8
Specificity (%) 100 100
Negative predictive
value (%)
93.7 93.7
Positive predictive
value (%)
100 100
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